17 Pulmonary Embolism Clinical Trials in Portland, OR (2026)

Q: How do I join a clinical trial in Portland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you.

Recruiting Pulmonary Embolism Studies in Portland

NCT06624215Recruiting

Retrospective Acute Care Appendectomy Study

The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis....

Portland, OR1,000 participantsIntuitive Surgical

View Study Details

NCT06628453Recruiting

CGM for Management of Type 2 Diabetes in Pregnancy

The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn...

Portland, ORNA564 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06293469Recruiting

Accelerated Flap Coverage in Severe Lower Extremity Trauma

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with o...

Portland, ORNA356 participantsJohns Hopkins University

View Study Details

NCT07676565Recruiting

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will e...

Portland, OR300 participantsIndiana University

View Study Details

NCT06067139Recruiting

Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

This study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program...

Portland, ORNA300 participantsKaiser Permanente

View Study Details

NCT06217302Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

Portland, ORPHASE3150 participantsAlessandro Doria

View Study Details

NCT06400004Recruiting

Lumason® Infusion vs. Bolus Administrations

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment ...

Portland, ORPHASE3106 participantsBracco Diagnostics, Inc

View Study Details

NCT06997588Recruiting

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS)....

Portland, ORPHASE2104 participantsNovartis Pharmaceuticals

View Study Details

NCT07062588Recruiting

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo....

Portland, ORPHASE280 participantsAngitia Incorporated Limited

View Study Details

NCT07600177Recruiting

Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

This is an investigator-initiated two-center study. The goal of this study is to investigate the feasibility, safety and efficacy outcomes of a seamless transition from mavacamten to aficamten in pati...

Portland, ORPHASE440 participantsOregon Health and Science University

View Study Details

NCT05184933Recruiting

Sleep and Circadian Mechanisms in Hypertension

This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN)....

Portland, ORNA32 participantsOregon Health and Science University

View Study Details

NCT05836259Recruiting

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

This is a first-in-human, non-randomized, open-label study designed to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-201 in adult patients with symptomatic hypertrophic cardiomyop...

Portland, ORPHASE130 participantsTenaya Therapeutics

View Study Details

NCT06133231Recruiting

Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported child behavior data and c...

Portland, ORNA30 participantsOregon Health and Science University

View Study Details

NCT03195556Recruiting

Augmentation of Limb Perfusion With Contrast Ultrasound

Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made...

Portland, ORNA30 participantsOregon Health and Science University

View Study Details

NCT06881992Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor-Associated Hyperinsulinism

The objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug for treatment of hypoglycemia in patients with Tumor-Associated Hyperinsulinism (tHI)....

Portland, ORPHASE316 participantsRezolute

View Study Details

NCT06676657Recruiting

Closed Loop Context Aware AID

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a high blood sugar detection and dosing algorithm for use within an AP control system...

Portland, ORNA10 participantsOregon Health and Science University

View Study Details

NCT03801434Recruiting

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders....

Portland, ORPHASE210 participantsWilliam Shomali

View Study Details

About Pulmonary Embolism Clinical Trials in Portland

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 17 pulmonary embolism clinical trials recruiting participants in Portland, OR. These studies are seeking a combined 3,158 participants. Research is being sponsored by Intuitive Surgical, University of Alabama at Birmingham, Johns Hopkins University and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Portland — FAQ

Are there pulmonary embolism clinical trials in Portland?

Yes, there are 17 pulmonary embolism clinical trials currently recruiting in Portland, OR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Portland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you about next steps.

Are clinical trials in Portland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Portland studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 17 active trials in Portland are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated September 2, 2026 from ClinicalTrials.gov